A detailed history of Buckingham Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 13,471 shares of PFE stock, worth $381,229. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,471
Previous 13,790 2.31%
Holding current value
$381,229
Previous $382,000 1.57%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$25.26 - $29.6 $8,057 - $9,442
-319 Reduced 2.31%
13,471 $376,000
Q1 2024

Apr 10, 2024

BUY
$25.89 - $29.73 $357,023 - $409,976
13,790 New
13,790 $382,000
Q3 2023

Oct 13, 2023

BUY
$32.09 - $37.51 $1,058 - $1,237
33 Added 0.53%
6,262 $207,000
Q2 2023

Jul 11, 2023

BUY
$36.12 - $41.79 $2,347 - $2,716
65 Added 1.05%
6,229 $228,000
Q1 2023

Apr 11, 2023

BUY
$39.39 - $51.28 $590 - $769
15 Added 0.24%
6,164 $251,000
Q4 2022

Jan 24, 2023

SELL
$41.75 - $54.5 $33,400 - $43,600
-800 Reduced 11.51%
6,149 $0
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $16,285 - $19,309
-350 Reduced 4.8%
6,949 $364,000
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $4,026 - $4,988
-88 Reduced 1.19%
7,299 $378,000
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $4,132 - $6,125
-100 Reduced 1.34%
7,387 $436,000
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $11,775 - $15,126
-300 Reduced 3.85%
7,487 $322,000
Q2 2021

Jul 27, 2021

SELL
$35.91 - $40.68 $33,396 - $37,832
-930 Reduced 10.67%
7,787 $305,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $1,440 - $1,624
-43 Reduced 0.49%
8,717 $316,000
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $381,189 - $484,715
-11,389 Reduced 56.52%
8,760 $322,000
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $12,922 - $15,160
-407 Reduced 1.98%
20,149 $739,000
Q2 2020

Jul 20, 2020

SELL
$30.12 - $36.54 $173,611 - $210,616
-5,764 Reduced 21.9%
20,556 $672,000
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $756,569 - $1.08 Million
-27,990 Reduced 51.54%
26,320 $859,000
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $157,719 - $178,991
-4,791 Reduced 8.11%
54,310 $2.13 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $122,357 - $158,661
-3,766 Reduced 5.99%
59,101 $2.12 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $211,081 - $236,996
-5,708 Reduced 8.32%
62,867 $2.72 Million
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $343,275 - $377,144
-9,154 Reduced 11.78%
68,575 $2.91 Million
Q4 2018

Feb 04, 2019

SELL
$38.47 - $43.86 $175,884 - $200,527
-4,572 Reduced 5.56%
77,729 $3.39 Million
Q3 2018

Nov 20, 2018

SELL
$34.47 - $41.81 $631,042 - $765,415
-18,307 Reduced 18.2%
82,301 $3.63 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $810,978 - $864,584
-24,590 Reduced 19.64%
100,608 $3.65 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $61,299 - $71,115
-1,921 Reduced 1.51%
125,198 $4.44 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $29,302 - $31,090
-881 Reduced 0.69%
127,119 $4.6 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $158,627 - $174,745
5,117 Added 4.16%
128,000 $4.57 Million
Q2 2017

Aug 10, 2017

BUY
N/A
122,883
122,883 $4.13 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Buckingham Capital Management, Inc. Portfolio

Follow Buckingham Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.